Ruffer LLP Pfizer Inc Transaction History

Ruffer LLP

$2.55 Billion
Q1 2024

A detailed history of Ruffer LLP transactions in Pfizer Inc stock. As of the latest transaction made, Ruffer LLP holds 5,907,658 shares of PFE stock, worth $165 Million. This represents 6.43% of its overall portfolio holdings.

Number of Shares

5,907,658

Previous 5,796,012 1.93%

Holding current value

$165 Million

Previous $167 Million 1.76%

% of portfolio

6.43%

Previous 6.53%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$25.89 - $29.73 $2.89 Million - $3.32 Million	111,646 Added 1.93%	5,907,658 $164 Million
Q4 2023 Feb 12, 2024	BUY	$26.13 - $33.94 $108 Million - $140 Million	4,133,786 Added 248.69%	5,796,012 $167 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $15.7 Million - $18.3 Million	489,177 Added 41.7%	1,662,226 $55.1 Million
Q2 2023 Aug 10, 2023	BUY	$36.12 - $41.79 $3.66 Million - $4.24 Million	101,370 Added 9.46%	1,173,049 $43 Million
Q1 2023 May 11, 2023	BUY	$39.39 - $51.28 $20 Million - $26.1 Million	508,764 Added 90.38%	1,071,679 $43.7 Million

Q4 2022 Feb 10, 2023	BUY	$41.75 - $54.5 $339,845 - $443,630	8,140 Added 1.47%	562,915 $28.9 Million
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $441,538 - $539,007	10,090 Added 1.85%	554,775 $23.9 Million
Q2 2022 Aug 05, 2022	SELL	$46.53 - $55.17 $1.58 Million - $1.87 Million	-33,949 Reduced 5.87%	544,685 $28.6 Million
Q1 2022 May 12, 2022	BUY	$45.75 - $56.69 $882,060 - $1.09 Million	19,280 Added 3.45%	578,634 $30 Million
Q4 2021 Feb 04, 2022	BUY	$41.32 - $61.25 $5.14 Million - $7.62 Million	124,464 Added 28.62%	559,354 $31.8 Million
Q3 2021 Nov 10, 2021	BUY	$39.25 - $50.42 $8.91 Million - $11.4 Million	227,047 Added 109.24%	434,890 $18.6 Million
Q2 2021 Aug 06, 2021	BUY	$35.91 - $40.68 $7.46 Million - $8.46 Million	207,843 New	207,843 $8.14 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ruffer LLP, based on Form 13F filings with the SEC.

News

Stay updated on Ruffer LLP with notifications on news.

Account